Combined Effect of Anticancer Agents and Cytochrome C Decorated Hybrid Nanoparticles for Liver Cancer Therapy

Hepatocellular carcinoma is an aggressive form of liver cancer that displays minimal symptoms until its late stages. Unfortunately, patient prognosis still remains poor with only 10% of patients surviving more than five years after diagnosis. Current chemotherapies alone are not offering efficient t...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Shakarchi, Wejdan, Alsuraifi, Ali, Abed, Mohammed, Abdullah, Marwan, Richardson, Alan, Curtis, Anthony, Hoskins, Clare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027273/
https://www.ncbi.nlm.nih.gov/pubmed/29649145
http://dx.doi.org/10.3390/pharmaceutics10020048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027273/
https://www.ncbi.nlm.nih.gov/pubmed/29649145
http://dx.doi.org/10.3390/pharmaceutics10020048

Ejemplares similares